Two-antibody cocktail provides broad protection against ebolaviruses Structural analysis shows how the antibodies work in a powerful synergy against the three major ebolavirus species.
November 17, 2021
LA JOLLA, CA A combination of two highly potent antibodies, first discovered in the blood of ebolavirus survivors, protects monkeys against the three most medically important ebolavirus species, according to a new study from scientists at Vanderbilt University Medical Center (VUMC), Scripps Research, and Galveston National Laboratory. The antibody cocktail is the first to provide such broad protection, and potentially will be a powerful weapon against future ebolavirus outbreaks.
In the study, published October 28 in Cell, the scientists conducted extensive preclinical tests of the antibody cocktail, showing its effectiveness against not only the best-known ebolavirus species, Zaire ebolavirus (EBOV) sometimes called Ebola virus but also Sudan ebolavirus (SUDV) and Bundibugyo ebolavirus (BDBV). The three ebolaviruses in recent decades have caused frequent hemorrhagic fever outbreaks in Africa, killing tens of thousands of people.
The researchers used low-temperature electron microscopy (cryo-EM) to map the structures of the antibodies bound to their target sites on ebolaviruses, showing how they work in complementary ways to neutralize these pathogens.
The synergy between these two antibodies is really unique and adds up to broader protection than any other antibody or combination has shown so far, said study co-lead author Charles Murin, PhD, a staff scientist at Scripps Research.
Murin led the structural analysis, sharing co-lead authorship with Pavlo Gilchuk, PhD, a postdoctoral research associate at Vanderbilt. Murin works in the laboratory of study co-author Andrew Ward, PhD, professor in the Department of Integrative Structural and Computational Biology at Scripps Research. The study's lead investigator was James Crowe Jr., MD, professor of Pediatrics and Pathology, Microbiology and Immunology at VUMC, and director of the Vanderbilt Vaccine Center.
The high lethality of ebolaviruses and their potential for rapid spread has driven efforts to find effective vaccines and treatments, including antibody-based therapies that could be given, for example, to provide immediate, short-term protection for people who have been exposed to these viruses. However, the antibody therapies and vaccines that have been developed to date provide protection only against EBOV.
The remarkable antibodies described in the new study, rEBOV-442 and rEBOV-515, were derived from antibody-making B cells that researchers recovered from the blood of two survivors of African EBOV outbreaks during 2013 to 2016.
The researchers conducted a battery of tests showing that the two antibodies have neutralization activity against not only EBOV but also SUDV and BDBV, draw immune cells to kill ebolavirus-infected cells in two distinct ways, and, when combined in a therapeutic cocktail, enhance each other's efficacy to provide very potent neutralization of all three viral species. The experiments showed that ebolaviruses subjected to the 442/515 cocktail also were much less likely to evolve escape mutants compared to other antibody combinations.
The researchers injected macaque and cynomolgus monkeys with lethal doses of EBOV, SUDV, and BDBV, and then injected them with two doses of the antibody cocktail starting on day 3 to 6 after the viral exposure. The cocktail protected the monkeys not only from death but also from signs of disease even from abnormal blood-test results. By contrast, monkeys who were given the virus but not the antibody cocktail succumbed in 7 to 14 days.
Murin's cryo-EM-based structural studies supported the protection trials by revealing the two distinct locations where the antibodies bind to the ebolavirus outer glycoprotein. His results confirmed that the -515 antibody in particular binds to a small site that is uniquely well conserved among the EBOV, SUDV, and BDBV species.
That structural information was really valuable in understanding why these antibodies work so well and so broadly when combined, Murin says.
The very promising results are the apparent culmination of years of work toward the discovery of such a potent, broad-acting antibody cocktail, and set the stage for scaled-up production of the antibodies, and experimental trials in humans during future ebolavirus outbreaks.
Pan-ebolavirus protective therapy by two multifunctional human antibodies was co-authored by Pavlo Gilchuk, Seth Zost, Rachel Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Robin Bombardi, Robert Carnahan, and James Crowe, Jr., of the Vanderbilt Vaccine Center; Charles Murin and Andrew Ward of Scripps Research; and Robert Cross, Philipp Ilinykh, Kai Huang, Natalia Kuzmina, Viktoriya Borisevich, Krystle Agans, Joan Geisbert, Alexander Bukreyev, and Thomas Geisbert of the Galveston National Laboratory.
The research was supported by the National Institutes of Health (U19 AI109711, U19 AI142785, U19 AI109762), the U.S. Department of Health and Human Services (HHSN272201400058C), the U.S. Defense Threat Reduction Agency (HDTRA1-13-1-0034), and Merck KGaA.
Infectious Diseases Integrative Structural & Computational Biology Ward, Andrew
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
01/05/2026
January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...
01/04/2026
January 4 2026, 18:00 (PST) DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION
Douyin Users Can Now Create And Share Videos With Stun...
28/01/2026
Top L-R: The Liars, Jazz Infernal, Living with a Visionary
Second Row L-R: Paper Trail, The Baddest Speechwriter of All, Crisis Actor
Third Row: The Boys and ...
28/01/2026
Music discovery should feel intuitive and personal. That's why we're continuing to give you more control, so you can ask for what you want, shape what y...
28/01/2026
Today, Charlie Hellman, Spotify's Head of Music, shared the following note on the Spotify for Artists blog that the company paid out more than $11 billion t...
28/01/2026
The National Film and Video Foundation (NFVF), in partnership with the Oudtshoorn Municipality, invites aspiring and emerging filmmakers to apply for the Sediba...
28/01/2026
As demand for more complex live sports coverage grows, Balkan broadcast specialist MVP has upgraded its flagship HD1 progressive OB truck with the installation ...
28/01/2026
Airlines, cruise and tour operators double down on ad spend as Australians' prioritise travel
Sydney January 28, 2026 - New Nielsen Ad Intel data shows a...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
Marshall Electronics launches the CV420-27X, its next-generation ultra-high-definition (UHD) IP camera, at ISE 2026 (Stand 4N900). Engineered for modern IP-base...
28/01/2026
Grass Valley has announced that Television Mobiles Ltd. (TVM), one of Europe's leading independent outside broadcast providers, has carried out a major refu...
28/01/2026
AI, graphics and virtual software power new production capabilities
FOR-A is bringing remarkable new technologies to FOMEX, the Future of Media Exhibition (ex...
28/01/2026
Continuing a longstanding collaboration, Riedel Communications and Nordic media technology company Media Tailor have once again joined forces to deliver a state...
28/01/2026
Pebble has appointed Paul Nagle-Smith as vice president for customer fulfilment, strengthening its senior leadership focus on customer delivery and operational ...
28/01/2026
Cloud playout solutions provider, Veset has announced that leading Mexican broadcaster, TV Azteca is using Veset Nimbus on AWS as a disaster recovery (DR) playo...
28/01/2026
Ensuring it can keep pace with a rapidly evolving live sports market, Balkan broadcast facility provider MVP Most Valuable Production has upgraded its flags...
28/01/2026
Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud solutions provider that powers and protects life online, and Yospace, the leader in dynamic ad insertion tec...
28/01/2026
The renowned Reykjavik City Theatre (RCT) recently underwent a major intercom system upgrade using Clear-Com solutions. This milestone project utilizes Clear-C...
28/01/2026
Luxembourg, January 26, 2026 - SES S.A. ( SES or the Company ), a leading space solutions company, acknowledges the credit rating action announced by Fitch to...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
28 01 2026 - Media release Screen Australia refreshes Market & Audience approach...
28/01/2026
Boston Conservatory Orchestra Premieres a New Piano Concerto by Peter and Leonar...
28/01/2026
28 Jan 2026
VEON Notes Kyivstar Group Publication of Selected Full Year 2025 Fi...
28/01/2026
Rohde & Schwarz to host 2026 edition of its online event Demystifying EMC Rohde & Schwarz invites the global EMC community to join a crucial discussion on pre...
28/01/2026
Back to All News
The Wait Is Over: Teaser Trailer Drops for Jo Nesbo's Dete...
28/01/2026
Back to All News
Netflix Announces a Fictional Miniseries Inspired by the Marta del Castillo Case
Entertainment
28 January 2026
GlobalSpain
Link copied to ...
28/01/2026
Back to All News
Netflix Announces Santiago Mitres New Film Starring Ver nica L...
28/01/2026
Back to All News
Netflix Unveils the Teaser Trailer for Berlin and the Lady wit...
28/01/2026
Stadtwerke Wolfhagen Modernize Customer Management with AEP.energysuite from Arv...
27/01/2026
Click for Japanese version
Tokyo, Japan - January 27, 2026 - Akamai Technolo...
27/01/2026
L-R: Jonathan Cuchacovich, Sonia Kennebeck, Alan Fischer, Daeil Kim, Andrew Sta...
27/01/2026
Today, Spotify is proud to support our partner Backline, an industry-leading men...
27/01/2026
With nearly 29 million monthly listeners and clear momentum on Spotify, Net n Ve...
27/01/2026
January 14, 2026
We are proud to share that 25 Ontario, First Gulf's commercial project located just two minutes from our head office, has been recognized ...
27/01/2026
January 22, 2026
First Gulf is excited to share that a full-building lease has been secured at 625 Bronte Rd in Oakville, part of Bronte Station Business Park,...
27/01/2026
January 23, 2026
First Gulf continues to demonstrate its commitment to high-performance, sustainable real estate with 351 King Street East achieving BOMA BEST ...
27/01/2026
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
27/01/2026
Nielsen will continue to drive growth and provide local audience measurement
in...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Amagi Media Labs Limited, the only cloud-native SaaS provider offering end-to-end solutions across live production, content preparation, distribution, and monet...
27/01/2026
Miri Technologies Inc. today unveiled its V410 live 4K video encoder/decoder for streaming, IP-based production workflows and AV-over-IP distribution. Designed ...
27/01/2026
The Paul E. Tsongas Center at UMass Lowell in Massachusetts has chosen Ikegami cameras for incorporation into its broadcast-quality television production facili...
Two-antibody cocktail provides broad protection against ebolaviruses Structural analysis shows how the antibodies work in a powerful synergy against the three major ebolavirus species.
